Comparison of tumor mutational burden (TMB) in relevant molecular subsets of metastatic urothelial cancer (MUC)
SK Pal , N Agarwal , TK Choueiri , PJ Stephens
Annals of Oncology 28 v297 -v297
10
2017
Analysis of POLE mutation and tumor mutational burden (TMB) across 80,853 tumors: Implications for immune checkpoint inhibitors (ICPIs)
AB Schrock , D Fabrizio , Y He , J Chung
Annals of Oncology 28 v415 -v415
13
2017
Comprehensive characterization of BRCA1 and BRCA2 alterations in circulating tumor DNA and tumor tissue in men with prostate cancer: Implications for clinical care
P Lara , J McPherson , W Heyer , R Hartmaier
Annals of Oncology 28 v287 -v287
2017
Targeted next generation sequencing identifies markers of response to PD-1 blockade. Cancer Immunol Res. 2016; 4: 959–67
DB Johnson , GM Frampton , MJ Rioth , E Yusko
7
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade. Cancer Immunol Res 2016; 4 (11): 959–67 doi 10.1158/2326-6066
DB Johnson , GM Frampton , MJ Rioth , E Yusko
CIR-16-0143.[Europe PMC free article][Abstract][CrossRef][Google Scholar]
6
Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
AJ Tarasen , RN Al-Rohil , K Wang , JV Rand
MODERN PATHOLOGY 27 205A -206A
2014
High Prevalent BRAF Alterations and TERT Promoter Mutations in Papillary Thyroid Carcinoma
K Wang , S Ganesan , A Johnson , JP Sharman
European Journal of Cancer 51 S583 -S583
1
2015
Efficacy of Unani medicine.
Ahmed Khalil , SM Ali , M Akram , HM Asif
Journal of Medicinal Plants Research 6 ( 22) 3806 -3809
2012
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017; 9: 1–14
ZR Chalmers , CF Connelly , D Fabrizio , L Gay
5
Comprehensive genomic profiling (CGP) of thymic gland carcinomas
JS Ross , P Vanden Borre , N Almog , AB Schrock
Annals of Oncology 28 x166 -x166
2017
Hybrid-capture based genomic profiling identifies BRAF V600 and non-V600 alterations in melanoma samples negative by prior testing
L Boussemart , A Wang , MKK Wong , JS Ross
Annals of Oncology 28 v437 -v437
2017
IMAGE: Individualized molecular analyses guide efforts in breast cancer with comprehensive genomic profiling of tissue and plasma tumor DNA
HA Parsons , JA Beaver , A Cimino-Mathews , J Zorzi
CANCER RESEARCH 76
2016
Comprehensive Genomic Profiling of Metaplastic Breast Carcinoma By Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
CE Sheehan , S Badve , K Wang , A Boguniewicz
MODERN PATHOLOGY 27 80A -80A
2014
Comprehensive Genomic Profiling of Gastric Carcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
SM Ali , K Wang , GA Otto , GA Palmer
LABORATORY INVESTIGATION 94 162A -162A
2014
Evaluation of Small Cell Undifferentiated Lung Cancer by Next Generation Sequencing Reveals Frequent Consistent Genomic Alterations
OR Elkadi , A Tarasen , LX Foulke , CE Sheehan
LABORATORY INVESTIGATION 94 476A -476A
2014
Evaluation of Advanced Stage Squamous Cell Carcinoma of the Skin by Next Generation Sequencing Opens the Door for new Routes to Targeted Therapies
RN Al-Rohil , AJ Tarasen , K Wang , CE Sheehan
LABORATORY INVESTIGATION 94 129A -130A
2014
Comprehensive Genomic Profiling of Adrenal Cortical Carcinoma Reveals Actionable Genomic Alterations and New Routes to Targeted Therapies
JV Rand , MJ Presta , K Wang , CE Sheehan
MODERN PATHOLOGY 27 158A -158A
2014
Targeted Next Generation Sequencing of Adenocarcinoma of Unknown Primary Site Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
JS Ross , K Wang , GA Otto , G Palmer
LABORATORY INVESTIGATION 94 529A -529A
2014
Cancer Forums and News by PhD's> Ovarian Cancer> Genomic Profiling by Next Generation Sequencing
JS Ross , SM Ali , K Wang , G Palmer
Gynecol Oncol 11 42 -42
2013
Default Genomic Profiling by Next Generation Sequencing
JS Ross , SM Ali , K Wang , G Palmer
Gynecol Oncol
2013
Alexa Schrock Garrett M Frampton Doron Lipson Sai-Hong Ignatius Ou Samuel Klempner, MD Zachary R Chalmers James X. Sun Roman Yelensky Sumanta Pal David M. Sabatini Shridar Ganesan Sugganth Daniel Dos Sarbassov Lee Albacker maurizio colecchia Do-Hyung Kim Alberto Briganti Christine M. Lovly, MD, PhD Andrea Gallina